Table 1 The drugs and treatment regimens used in treatment of women with Covid-19 infection
From: Covid-19 infection in pregnant women in Dubai: a case-control study
Generic name | Dose | Duration |
|---|---|---|
Hydroxychloroquine | Two loading doses of 400 mg followed by 200 mg twice daily | 7-14 days |
Chloroquine base | 300 mg (base) twice daily | 5-7 days |
Lopinavir-Ritonavir (200mg/50mg) | 400mg/100mg twice daily | 5-7 days (maximum 14 days) |
Favipiravir | Two loading doses of 1600 mg over 1 day followed by 600 mg twice daily | 5-7 days |
Tocilizumab | 4-8 mg/kg (max 400 mg) followed by a second dose after 8-12 hours, and then a third dose 8-12 hours later | 3 doses within 24 hours |
Pegylated interferon | 180 mcg, maximum of 2 doses 1 week apart | 2 doses within one week |
Low Molecular Weight Heparin (LMWH) [Prophylactic] | According to Body weight: 50-90kg: 40mg once daily. 91-130kg: 60mg once daily. 131-170kg: 80mg once daily. | Till clinical improvement |
Low Molecular Weight Heparin (LMWH)-Therapeutic in critical Covid-19 pneumonia patients | 50-90kg: 40mg twice daily 91-130kg: 60mg twice daily 131-170kg: 80mg twice daily | Till clinical improvement |
Methylprednisolone | 0.5-1 mg/kg in 2 divided doses | 3 days in Non-ICU & 5-7 days in ICU patients. |
N-acetyl cysteine | Two 1200 mg doses followed by 600 mg thrice daily | 7-14 days |